Evidence map›Paper›PMID 29276085›Full record

ArticleMolecular cell2018

Molecular Mechanisms for CFIm-Mediated Regulation of mRNA Alternative Polyadenylation.

Yong Zhu, Xiuye Wang, Elmira Forouzmand, Joshua Jeong, Feng Qiao, Gregory A Sowd, Alan N Engelman, Xiaohui Xie, Klemens J Hertel, Yongsheng Shi

Open access · bronzeAbstract read
In one paragraph

Article in Molecular cell, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 144 papers.

0numbers the graph read from it
0cells of the map it votes in
144citing papers in PubMed
7.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

144 citing papers in PubMed, 232 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Coordinated DNA 5-mC and RNA mExperimental & molecular medicine · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. The Role of mRNA Alternative Processing in Mammalian Neurodevelopment.International journal of molecular sciences · 2025
    Review
  20. Article

84 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Yong ZhuDepartment of Microbiology and Molecular Genetics, School of Medicine, University of California, Irvine, Irvine, CA 92697, USA.
Xiuye WangDepartment of Microbiology and Molecular Genetics, School of Medicine, University of California, Irvine, Irvine, CA 92697, USA.
Elmira ForouzmandInstitute for Genomics and Bioinformatics, University of California, Irvine, Irvine, CA 92697, USA; Department of Computer Science, University of California, Irvine, Irvine, CA 92697, USA.
Joshua JeongDepartment of Microbiology and Molecular Genetics, School of Medicine, University of California, Irvine, Irvine, CA 92697, USA.
Feng QiaoDepartment of Biological Chemistry, School of Medicine, University of California, Irvine, Irvine, CA 92697, USA.
Gregory A SowdDepartment of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA.
Alan N EngelmanDepartment of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA.
Xiaohui XieInstitute for Genomics and Bioinformatics, University of California, Irvine, Irvine, CA 92697, USA; Department of Computer Science, University of California, Irvine, Irvine, CA 92697, USA.
Klemens J HertelDepartment of Microbiology and Molecular Genetics, School of Medicine, University of California, Irvine, Irvine, CA 92697, USA.
Yongsheng ShiDepartment of Microbiology and Molecular Genetics, School of Medicine, University of California, Irvine, Irvine, CA 92697, USA. Electronic address: yongshes@uci.edu.
University of California, Irvine · USDana-Farber Cancer Institute · US

Funding

Univ.of Calif., Irvine Cancer Center Support GrantP30CA062203 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI Christine Hui · 1994 to 2026
$57.9M
Nuclear Localization of HIV-1 Preintegration ComplexesR01AI052014 · NIAID · DANA-FARBER CANCER INSTITUTE · PI ENGELMAN, ALAN N. · 2003 to 2025
$11.4M
MECHANISMS OF ENHANCER DEPENDENT SPLICE SITE ACTIVATIONR01GM062287 · NIGMS · UNIVERSITY OF CALIFORNIA-IRVINE · PI HERTEL, KLEMENS J · 2001 to 2019
$4.8M
Characterization of the mammalian mRNA-3'-end processing complexR01GM090056 · NIGMS · UNIVERSITY OF CALIFORNIA-IRVINE · PI SHI, YONGSHENG · 2010 to 2022
$4.2M
Coordinated regulation of alternative pre-mRNA processing in colon cancerR01CA177651 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI EDWARDS, ROBERT ANDREW, HERTEL, KLEMENS J · 2014 to 2018
$2.4M
HSRD VA CDP 12-186NCI NIH HHS P30 CA062203NCI NIH HHS R01 CA177651NIAID NIH HHS R01 AI052014NIGMS NIH HHS R01 GM062287NIGMS NIH HHS R01 GM090056
6 · The paper itself

Abstract

Alternative mRNA processing is a critical mechanism for proteome expansion and gene regulation in higher eukaryotes. The SR family proteins play important roles in splicing regulation. Intriguingly, mammalian genomes encode many poorly characterized SR-like proteins, including subunits of the mRNA 3'-processing factor CFIm, CFIm68 and CFIm59. Here we demonstrate that CFIm functions as an enhancer-dependent activator of mRNA 3' processing. CFIm regulates global alternative polyadenylation (APA) by specifically binding and activating enhancer-containing poly(A) sites (PASs). Importantly, the CFIm activator functions are mediated by the arginine-serine repeat (RS) domains of CFIm68/59, which bind specifically to an RS-like region in the CPSF subunit Fip1, and this interaction is inhibited by CFIm68/59 hyper-phosphorylation. The remarkable functional similarities between CFIm and SR proteins suggest that interactions between RS-like domains in regulatory and core factors may provide a common activation mechanism for mRNA 3' processing, splicing, and potentially other steps in RNA metabolism.

Indexed as

PolyadenylationAlternative SplicingAnimalsCell LineEnhancer Elements, GeneticGene Expression RegulationGene Knockout TechniquesHEK293 CellsHumansmRNA Cleavage and Polyadenylation FactorsPhosphorylationPoly AProtein DomainsRNA-Binding ProteinsRNA, MessengerSf9 Cellscleavage factor Im, humanFIP1L1 protein, humanmRNA Cleavage and Polyadenylation FactorsPoly ARNA-Binding ProteinsRNA, Messengeralternative polyadenylationcleavagemRNA 3′ processingpolyadenylationRNA-binding proteinssplicingSR proteins

Identifiers

PMID29276085
PMCPMC5756121
OpenAlexW2776451827

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.